Department of Health, Philippines Report issue

Government Phase 3

Organization Overview

First Clinical Trial
2003
NCT00229775
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Department of Health, Philippines

Active Ingredients

Drugs in Phase 3 Trials (1)

favipiravir (1 trial)

Drugs in Other Trials (5)

chloroquine (1 trial)

coartem (1 trial)

lumefantrine (Coartem) (1 trial)

pyrimethamine (daraprim) (1 trial)

sulfadoxine (1 trial)

Indications

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 6